04Oct
04Oct
ESight launches next generation eye wear for visually impaired
The eye wear technology company, eSight, has launched the third generation of its hands-free glasses that provide instant sight and mobility for those with impaired vision. Read more >>
04Oct
Siamab Therapeutics Presents New Data at AACR’s Ovarian Cancer Conference Demonstrating its Anti-STn Antibody Therapeutics Inhibit Tumor Growth in Ovarian Cancer Models
Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced the presentation of new preclinical data for its novel anti-Sialyl-Tn (STn) antibodies and antibody drug conjugates (ADCs) that show inhibition of tumor progression in in vivo and in vitro patient derived xenograft (PDX) ovarian cancer models with complete regression in some treatment arms. Read more >>
01Oct
Applying for Angel Funding- Part 1: An Angel’s Perspective: Hub Angels, Launchpad, Golden Seeds & Boston Harbor Angels give their perspectives
Member David Kessler representing Boston Harbor Angels at this interactive session on Tuesday, October 3! Applying for Angel Funding- Part 1: An Angel’s Perspective. Read more >>
01Oct
Electronic glasses improve sight of legally blind teen
A teen who is legally blind from Bucks County is getting help from electronic glasses that help to improve his sight. Read more >>
30Sep
Commercial breakthrough for fishmeal alternative
KnipBio has received order for several tonnes of its innovative fishmeal alternative, KnipBio Meal (KBM). Read more >>
30Sep
Siamab Therapeutics Presented New Data for its Anti-STn Antibody Therapeutics Showing Myeloid-Derived Suppressor Cells as a Promising Cancer Immunotherapy Target at Cambridge Healthtech Institute’s Targeting Tumor Myeloid Cells Conference
Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced it presented new preclinical data for its novel anti-Sialyl-Tn (STn) antibodies and antibody drug conjugates (ADCs) targeting myeloid-derived suppressor cells (MDSCs) at Cambridge Healthtech Institute’s Inaugural Targeting Tumor Myeloid Cells Conference, held September 27-28, 2017 in Boston. Read more >>
27Sep
Bible Hill woman hopes to raise funds for a device that can enhance her vision
Most of us take such things for granted – reading print at a comfortable distance, identifying which car is yours in the parking lot or comprehending what another person is doing just across the room. Advertisement For Tammy Martin, the ability to perform such feats stirs a sense of awe. Tammy was born with optic nerve hypoplasia, a condition where the optic nerves are underdeveloped. She has poor depth perception and everything appears very small, as if she were a considerable distance away....
25Sep
Wearable assistive technology will hit the runway at Invictus showcase
Electronic glasses for the visually impaired — including people who haven’t been able to see their entire lives — will be among the 48 exhibits at this week’s Accessibility Innovation Showcase, an official event of the 2017 Invictus Games. Read more >>
24Sep